The BioMimics 3D Vascular Stent System approved in Japan

The BioMimics 3D Vascular Stent System received Shonin regulatory approval in Japan.

On December 19th, 2019, Japanese MHLW PMDA granted Marketing Pre-Market Approval (“Shonin”) for BioMimics 3D Vascular Stent System to improve luminal diameter during endovascular intervention in patients with symptomatic peripheral arterial disease in the femoropopliteal artery. The approved indication includes placement of the BioMimics 3D stent in treating acute or impending occlusion associated with unsuccessful interventional treatment. Veryan will announce plans for BioMimics 3D commercialization in Japan in due course.Download PDF